Page 3 - Kenta Noguchi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A PCR test shows whether the novel coronavirus sampled is a variant. (Provided by the Ibaraki prefectural institute for health) About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel coronavirus, having produced antibodies stimulated to better fight them off, Japanese researchers said on May 12. The vaccine is the only one currently available in Japan. A team of researchers at Yokohama City University reported the vaccine has a high efficacy against variants after analyzing how it protects against the original form of the virus and seven types of variants, including those believed to be highly contagious and can elude the immune system.

South africaUnited kingdomTakeharu yamanakaNatsumi nakaiKenta noguchiNational institute of infectious diseasesYokohama city universityNational instituteInfectious diseasesCity universityஒன்றுபட்டது கிஂக்டம்கெந்த நொக்யூசிதேசிய நிறுவனம் ஆஃப் தொற்று நோய்கள்யோகோகாமா நகரம் பல்கலைக்கழகம்தேசிய நிறுவனம்தொற்று நோய்கள்